Benjamin A. Rogers

Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With <i>E coli</i> or <i>Klebsiella pneumoniae</i> Bloodstream Infection and Ceftriaxone Resistance

Patrick N. A. Harris, Paul Anantharajah Tambyah, David Chien Lye et al. · JAMA · 2018 · 770 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

Global dissemination of a multidrug resistant <i>Escherichia coli</i> clone

Nicola K. Petty, Nouri L. Ben Zakour, Mitchell Stanton‐Cook et al. · Proceedings of the National Academy of Sciences · 2014 · 559 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia

Steven Y. C. Tong, David Chien Lye, Dafna Yahav et al. · JAMA · 2020 · 275 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial

George R. Thompson, Àlex Soriano, Oliver A. Cornely et al. · The Lancet · 2022 · 168 citations · Full text

Life Sciences, Microbiology, Pharmacology +16

Association Between Minimum Inhibitory Concentration, Beta-lactamase Genes and Mortality for Patients Treated With Piperacillin/Tazobactam or Meropenem From the MERINO Study

Andrew Henderson, David L. Paterson, Mark D. Chatfield et al. · Clinical Infectious Diseases · 2020 · 158 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +15